Works matching IS 22143599 AND DT 2023 AND VI 10 AND IP 4
Results: 21
Dyslipidemia in Muscular Dystrophy: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 505, doi. 10.3233/JND-230064
- By:
- Publication type:
- Article
Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 701, doi. 10.3233/JND-230036
- By:
- Publication type:
- Article
Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 719, doi. 10.3233/JND-230032
- By:
- Publication type:
- Article
Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 555, doi. 10.3233/JND-230029
- By:
- Publication type:
- Article
Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 685, doi. 10.3233/JND-230019
- By:
- Publication type:
- Article
Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 541, doi. 10.3233/JND-230018
- By:
- Publication type:
- Article
MYH2-related Myopathy: Expanding the Clinical Spectrum of Chronic Progressive External Ophthalmoplegia (CPEO).
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 727, doi. 10.3233/JND-230017
- By:
- Publication type:
- Article
Diagnostic Challenges of Neuromuscular Disorders after Whole Exome Sequencing.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 667, doi. 10.3233/JND-230013
- By:
- Publication type:
- Article
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 653, doi. 10.3233/JND-230012
- By:
- Publication type:
- Article
Development of an International SMA Bulbar Assessment for Inter-professional Administration.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 639, doi. 10.3233/JND-221672
- By:
- Publication type:
- Article
Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 627, doi. 10.3233/JND-221658
- By:
- Publication type:
- Article
Brain MRI Abnormalities, Epilepsy and Intellectual Disability in LAMA2 Related Dystrophy – a Genotype/Phenotype Correlation.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 483, doi. 10.3233/JND-221638
- By:
- Publication type:
- Article
Subjective Sleep Quality as it Relates to Cognitive and Physical Function in Spinal Muscular Atrophy Patients.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 713, doi. 10.3233/JND-221627
- By:
- Publication type:
- Article
Phenotype Genotype Characterization of FKRP-related Muscular Dystrophy among Indian Patients.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 615, doi. 10.3233/JND-221618
- By:
- Publication type:
- Article
A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular Dystrophy.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 593, doi. 10.3233/JND-221617
- By:
- Publication type:
- Article
RNA Transcript Diversity in Neuromuscular Research.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 473, doi. 10.3233/JND-221601
- By:
- Publication type:
- Article
Life Experiences in Neuromuscular Tracheotomized Patients in Times of Covid-19.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 517, doi. 10.3233/JND-221597
- By:
- Publication type:
- Article
Muscle Specific Promotors for Gene Therapy – A Comparative Study in Proliferating and Differentiated Cells.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 575, doi. 10.3233/JND-221574
- By:
- Publication type:
- Article
Brain Magnetic Resonance Imaging (MRI) in Spinal Muscular Atrophy: A Scoping Review.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 493, doi. 10.3233/JND-221567
- By:
- Publication type:
- Article
Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 531, doi. 10.3233/JND-221531
- By:
- Publication type:
- Article
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 567, doi. 10.3233/JND-221556
- By:
- Publication type:
- Article